Chosen non-enzymatic substances that participate in a protection against overproduction of free radicals;Wybrane substancje nieenzymatyczne uczestniczace w procesie obrony przed nadmiernym wytwarzaniem wolnych rodników

Polski Merkuriusz Lekarski

Volumn 25, Issue 147, 2008, Pages 269-272

  Gałecka, Elzbieta ^a,b   Mrowicka, Małgorzata ^a   Malinowska, Katarzyna ^a   Gałecki, Piotr ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Free radicals; Non enzymatic antioxidants

Indexed keywords

ANTIOXIDANT; FREE RADICAL; GLUTATHIONE; MELATONIN; THIOREDOXIN; VITAMIN;

HUMAN; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW;

ANTIOXIDANTS; FREE RADICALS; GLUTATHIONE; HUMANS; MELATONIN; OXIDATIVE STRESS; THIOREDOXINS; VITAMINS;

EID: 54149101887     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Bilska A., Kryczyk A., Włodek L.: Różne oblicza biologicznej roli glutationu. Post. Hig. Med., 2007, 61, 438-453.
2. Bourdon E., Loreau N., Blache D.: Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB, 1999, 13, 233-244.
3. Brenneisen P.: Selenium, oxidative stress, and human health. Mol. Aspect. Med., 2005, 26, 256-267.
4. Bronowicz R., Dutkiewicz S., Iwanicki J.: Znaczenie selenu w profilaktyce raka stercza. Lek. w Pdsce, 2007, 5, 62-69.
5. Czarna M., Jarmuszkiewicz W.: Rola mitochondrión w wytwarzaniu i usuwaniu reaktywnych form tlenu; zwiazek z przesyłaniem sygnałów i programowana. śmiercia komórki. Post. Bioch., 2006, 52, 2, 145-155.
6. Czuczejko J., Zachara B., Staubach-Topaczewska E. i wsp.: Selenium, gluthatione and gluthatione peroxidase in blond of patients with chronic liver diseases. Acta Biochim. Pol., 2003, 50, 1147-1154.
7. De la Lastra C.A., Villegasi I.: Resveratrol as an antioxidant and prooxidant agent: mechanism and clinical implications. Biochem. Soc. Trans., 2007, 35, 1156-1160.
8. Galvano F., Fauci L.L., Lazzarino G., Fogliano V. i wsp.: Cyanidins: metabolism and biological properties. J. Nutr. Biochem., 2004, 15, 2-11.
9. Giovannini C., Filesi C., D'Archivio M. i wsp.: Polyphenols and endogenous antioxidant defense: effects on glutathione and glutathione related enzymes. Ann. Ist Super Sanita., 2006, 42, 336-347.
10. Giurgea N., Constantinescu M.I., Sranciu R. i wsp.: Ceruloplasmin- acute-phase reactant or endogenous antioxidant? The case of cardiovascular disease. Med. Sci. Monit., 2005, 11, 48-51.
11. Guz J., Dziaman T., Szpila A.: Czy witaminy antyoksydacyjne maja wpływ na process karcynogenezy. Pos. Med. Hig., 2007, 61, 185-198.
12. Holmgren A., Johansson C., Berndt C. i wsp.: Thiol redox control via thioredoxin and glutaredoxin system. Wioch. Soc. Transact., 2005, 33, 1375-1377.
13. Karbownik M., Reiter R.J.: Antioxidative Effects of melatonin in protection against cellular damage caused by ionizing radiation. PSEBM. 2000, 225, 9-22.
14. Komatowska-Kedziora K., Szewczyk-Golec K., Czuczejko J. i wsp.: Effect of melatonin on the oxidative stress in erythrocytes of healthy young and elderly subjects. J. Pineal Res., 2007, 42, 153-158.
15. Michalska M., Wasek M.: Vitamina C jak: cud antyoksydacyjny. Cz. I. Lek. w Polsce, 2006, 7, 42-47.
16. Oteiza P.I., Mackenzie G.G.: Zinc, oxidant-triggered cell signaling, and human health. Mol. Aspect. Med., 2005, 26, 245-255.
17. Palace V.P., Hill M.F., Khaper N. i wsp.: Metabolism of vitamin A in the heart increases after a myocardial infection. Free Radic. Biol. Med., 1999, 26, 1501-1507.
18. Paslore A., Federici G., Bertini E., Piemonte F.: Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta, 2003, 333, 19-39.
19. Rahman I., Biswas S.K., Kirkham PA: Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol., 2006, 72, 1439-1452.
20. Ramassamy Ch.: Emerging role of polypnenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular target. Eur. J. Pharmacol., 2006, 545, 51-64.
21. Raiter R.J., Tan D.X., Gitto E. i wsp.: Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol. J. Pharmacol., 2004, 56, 159-170.
22. Reiter R.J., Tan D.X., Mayo J.C. i wsp.: Melatonin as an antioxidant biochemical mechanisms and patophysiological implication in humans. Acta Biochim. Pol., 2000, 50, 1129-1146.
23. Rutkowski M., Grzegorczyk K., Chojnacki J. i wsp.: Właś ciwości antyoksydacyjne witaminy E podstawa. jej nowych zastosowań w terapii. Pol. Merit. Lek., 2006, XX, 609-614.
24. Tapiero H., Tew K.D.: Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed. Pharmacotherapy, 2003, 57, 399-411.
25. Temple M.D., Perrone G.G., Dawes I.W.: Complex cellular response to reactive oxygen species. Trends In Cell Biol., 2005, 15, 319-326.
26. Uriu-Adams J.Y, Keen C.L.: Copper, oxidative stress, and human health. Mol. Asped. Med., 2005, 26, 268-298.
27. Valko M., Leibfritz D., Moncol J. i wsp.: Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol., 2007, 39, 44-84.
28. Valko M., Rhodes C.J., Moncol J. i wsp.: Free radicals, metals, and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact., 2006, 10, 1-40.